InvestorsHub Logo
icon url

chickpea598

11/30/17 10:58 AM

#42262 RE: Titan V #42261

TNBC would probably follow the same regulatory pathway as the melanoma combo with fast track and orphan drug designations. That seems like a likely possibility if PISCES is successfull.